Literature DB >> 8252383

beta-Amyloid peptides induce degeneration of cultured rat microglia.

A R Korotzer1, C J Pike, C W Cotman.   

Abstract

Microglia are often associated with senile plaques, a primary pathological hallmark of Alzheimer's disease (AD) that consists largely of insoluble deposits of beta-amyloid (A beta) protein. Synthetic A beta peptides have been shown to induce neurite dystrophy and neuronal death in vitro when the peptides are assembled into aggregates. We now report that assembled A beta peptides induce morphological evidence of degeneration in process-bearing microglia in vitro, as well as metabolic dysfunction in microglial cultures, but a non-assembling scrambled sequence A beta peptide does not.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8252383     DOI: 10.1016/0006-8993(93)90068-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

1.  N-terminal engineering of amyloid-β-binding Affibody molecules yields improved chemical synthesis and higher binding affinity.

Authors:  Joel Lindgren; Anna Wahlström; Jens Danielsson; Natalia Markova; Caroline Ekblad; Astrid Gräslund; Lars Abrahmsén; Amelie Eriksson Karlström; Sebastian K T S Wärmländer
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

2.  Effects of transforming growth factor-beta (isoforms 1-3) on amyloid-beta deposition, inflammation, and cell targeting in organotypic hippocampal slice cultures.

Authors:  M E Harris-White; T Chu; Z Balverde; J J Sigel; K C Flanders; S A Frautschy
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

3.  Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease.

Authors:  F Yang; X Sun; W Beech; B Teter; S Wu; J Sigel; H V Vinters; S A Frautschy; G M Cole
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

Review 4.  Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease.

Authors:  R J Mark; E M Blanc; M P Mattson
Journal:  Mol Neurobiol       Date:  1996-06       Impact factor: 5.590

Review 5.  Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration.

Authors:  Juan A Orellana; Pablo J Sáez; Kenji F Shoji; Kurt A Schalper; Nicolás Palacios-Prado; Victoria Velarde; Christian Giaume; Michael V L Bennett; Juan C Sáez
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

6.  Microglia in the aging brain: relevance to neurodegeneration.

Authors:  Xiao-Guang Luo; Jian-Qing Ding; Sheng-Di Chen
Journal:  Mol Neurodegener       Date:  2010-03-24       Impact factor: 14.195

7.  Amyloid beta-derived neuroplasticity in bone marrow-derived mesenchymal stem cells is mediated by NPY and 5-HT2B receptors via ERK1/2 signalling pathways.

Authors:  H K Jin; J S Bae; S Furuya; J E Carter
Journal:  Cell Prolif       Date:  2009-07-13       Impact factor: 6.831

8.  Neurocytopathic effects of beta-amyloid-stimulated monocytes: a potential mechanism for central nervous system damage in Alzheimer disease.

Authors:  J A London; D Biegel; J S Pachter
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

9.  Raft aggregation with specific receptor recruitment is required for microglial phagocytosis of Abeta42.

Authors:  Dixie-Ann Persaud-Sawin; Lynna Banach; Gaylia Jean Harry
Journal:  Glia       Date:  2009-02       Impact factor: 7.452

10.  Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.

Authors:  Wolfgang J Streit; Heiko Braak; Qing-Shan Xue; Ingo Bechmann
Journal:  Acta Neuropathol       Date:  2009-06-10       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.